Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/140737
Title: | Bioequivalence Study of Two Long-Acting Formulations of Oxytetracycline Following Intramuscular Administration in Bovines |
Author: | Mestorino, Nora Marchetti, María Laura Lucas, Mariana Florencia Modamio Charles, Pilar Zeinsteger, Pedro Fernández Lastra, Cecilia Segarra, Ignacio Mariño Hernández, Eduardo L. |
Keywords: | Farmacocinètica Farmàcia clínica Assaigs clínics de medicaments Pharmacokinetics Clinical pharmacy Drug testing |
Issue Date: | 23-Jun-2016 |
Publisher: | Frontiers Media |
Abstract: | The aim of this study was to evaluate the bioequivalence of two commercial long-acting formulations based on oxytetracycline (OTC) hydrochloride between the reference formulation (Terramycin LA, Pfizer) and a test formulation (Cyamicin LA, Fort Dodge Saude Animal). Both formulations were administered in a single intramuscular route at a dose of 20 mg OTC/kg of body weight in clinically healthy bovines. The study was carried out according to a one-period parallel design. Plasma samples were analyzed by high-pressure liquid chromatography. The limit of quantitation was 0.050 μg/mL with an accuracy of 101.67% with a coefficient of variation of 13.15%. Analysis of variance and 90% confidence interval tests were used to compare the bioavailability parameters (maximum plasma concentration, Cmax, and the area under the concentration-versus-time curve extrapolated to infinity, AUC0-∞) of both products. In the case of the time to maximum concentration (Tmax), non-parametric tests based on Wilcoxon's signed rank test were preferred. The comparison of the mean AUC0-∞ values did not reveal any significant differences (311.40 ± 93.05 μg h/mL and 287.71 ± 45.31 μg h/mL, respectively). The results were similar for the Tmax (3.58 ± 0.90 h versus 3.42 ± 0.51 h). However, when comparing the mean Cmax some significant differences were found (8.73 ± 3.66 μg/mL and 10.43 ± 3.84 μg/mL, respectively). The 90% confidence intervals for the ratio of AUC0-∞ and Tmax values for the reference and test product are within the interval 80-125%, but the 90% confidence intervals for the ratio of Cmax falls outside the proposed interval. It was concluded that Cmax of test product are not within the 20% of those of the reference, thus suggesting that test OTC is not bioequivalent to the reference formulation. Keywords: oxytetracycline, pharmacokinetics, AUC, Cmax, Tmax, bioequivalence, bovines |
Note: | Reproducció del document publicat a: https://doi.org/10.3389/fvets.2016.00050 |
It is part of: | Frontiers in Veterinary Sciences, 2016, vol. 3, num. 50 |
URI: | http://hdl.handle.net/2445/140737 |
Related resource: | https://doi.org/10.3389/fvets.2016.00050 |
ISSN: | 2297-1769 |
Appears in Collections: | Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
662964.pdf | 403.59 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License